Previously, it was identified that Mapk10 (JNK3) could be inactivated in multiple lymphomas and carcinomas by epigenetic methylation, albeit only few studies have addressed this concern (Ying et al., 2006). The gene discussed is MAPK10; the disease is lymphoma.